Early changes in gene expression and inflammatory proteins in systemic juvenile idiopathic arthritis patients on canakinumab therapy

被引：0

作者：

Arndt H. Brachat

Alexei A. Grom

Nico Wulffraat

Hermine I. Brunner

Pierre Quartier

Riva Brik

Liza McCann

Huri Ozdogan

Lidia Rutkowska-Sak

Rayfel Schneider

Valeria Gerloni

Liora Harel

Maria Terreri

Kristin Houghton

Rik Joos

Daniel Kingsbury

Jorge M. Lopez-Benitez

Stephan Bek

Martin Schumacher

Marie-Anne Valentin

Hermann Gram

Ken Abrams

Alberto Martini

Daniel J. Lovell

Nanguneri R. Nirmala

Nicolino Ruperto

机构：

[1] Novartis Institutes for Biomedical Research,

[2] Cincinnati Children’s Hospital Medical Center,undefined

[3] PRCSG,undefined

[4] Wilhelmina Kinderziekenhuis,undefined

[5] Department of Pediatric Immunology and Rheumatology,undefined

[6] Université Paris-Descartes,undefined

[7] IMAGINE Institute,undefined

[8] Hôpital Necker-Enfants Malades. Centre de référence national pour les Arthrites Juveniles,undefined

[9] Unité d’Immunologie,undefined

[10] Hématologie et Rhumatologie Pediatrique,undefined

[11] Rambam Medical Center,undefined

[12] Department of Pediatrics B,undefined

[13] Alder Hey Children’s NHS Foundation Trust,undefined

[14] Cerrahpasa Tip Fakultesi,undefined

[15] Ic Hastaliklari ABD,undefined

[16] Romatoloji BD,undefined

[17] Institute of Rheumatology,undefined

[18] Paediatric Clinic,undefined

[19] Hospital for Sick Children,undefined

[20] Division of Rheumatology,undefined

[21] Istituto Gaetano Pini,undefined

[22] Divisione di Reumatologia,undefined

[23] Schneider Childrens Medical Center,undefined

[24] Pediatric Rheumatology Unit,undefined

[25] Universidade Federal de São Paulo,undefined

[26] Pediatrics,undefined

[27] British Columbia Children’s Hospital,undefined

[28] Universitair Ziekenhuis Gent,undefined

[29] Centrum Voor Kinderreumatologie,undefined

[30] Randall Children’s Hospital at Legacy Emanuel,undefined

[31] Floating Hospital for Children,undefined

[32] Rheumatology NEMC 286,undefined

[33] Novartis Pharmaceuticals Corporation,undefined

[34] University of Genova and Istituto Giannina Gaslini,undefined

[35] Pediatria II-PRINTO,undefined

[36] Novartis Institutes for Biomedical Research,undefined

[37] Istituto Giannina Gaslini,undefined

[38] Pediatria II-PRINTO,undefined

来源：

Arthritis Research & Therapy | / 19卷

关键词：

Biomarkers; Canakinumab; Gene expression; Interleukin-1β; Juvenile idiopathic arthritis; SJIA;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[41] Early Treatment with Anakinra in Systemic Juvenile Idiopathic Arthritis
Pardeo, Manuela
Bracaglia, Claudia
Sacco, Emanuela
Marafon, Denise Pires
Insalaco, Antonella
Marucci, Giulia
Nicolai, Rebecca
Messia, Virginia
De Benedetti, Fabrizio
ARTHRITIS & RHEUMATOLOGY, 2020, 72 : 174 - 175
[42] EXPERIENCE WITH INTERLEUKIN-1 INHIBITOR CANAKINUMAB IN AUTO-INFLAMMATORY DISEASES AND SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS IN CLINICAL PRACTICE
Salugina, S. O.
Kaleda, M.
Fedorov, E.
Nikishina, I.
ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 622 - 622
[43] Early Aggressive Therapy for Patients with Juvenile Idiopathic Arthritis: Are We There Yet?
Berard, Roberta A.
Laxer, Ronald M.
JOURNAL OF RHEUMATOLOGY, 2014, 41 (12) : 2343 - 2346
[44] EFFICACY AND SAFETY OF CANAKINUMAB IN SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS - EXPERIENCE USING DATA OF THE BIKER REGISTRY
Horneff, Gerd
Lilienthal, Eggert
Trauzeddel, Ralf
Hospach, Toni
Kallinich, Tilmann
Dressler, Frank
Sailer-Hoeck, Michaela
Ganser, Gerd
Weller-Heinemann, Frank
Heubner, Georg
Urban, Andreas
Ruehlmann, Michael
Rietschel, Christoph
Hufnagel, Markus
Emminger, Wolfgang
Klein, Ariane
ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 966 - 966
[45] Long term efficacy and safety of canakinumab in children with systemic juvenile idiopathic arthritis with and without fever
Horneff G.
Ruperto N.
Brunner H.
Quartier P.
Constantin T.
Alexeeva E.
Kone-Paut I.
Marzan K.
Wulffraat N.
Schneider R.
Padeh S.
Chasnyk V.
Wouters C.
Deschner J.K.
Kallinich T.
Lauwerys B.
Haddad E.
Nasonov E.
Trachana M.
Vougiouka O.
Abrams K.
Leon K.
Lheritier K.
Martini A.
Lovell D.
Pediatric Rheumatology, 13 (Suppl 1)
[46] Inflammatory Bowel Disease in Children With Systemic Juvenile Idiopathic Arthritis
Maller, Justine
Fox, Emily
Park, K. T.
Paul, Sarah Sertial
Baszis, Kevin
Borocco, Charlotte
Prahalad, Sampath
Quartier, Pierre
Reinhardt, Adam
Schonenberg-Meinema, Dieneke
Shipman-Duensing, Lauren
Terreri, Maria Teresa
Simard, Julia
Lavi, Idit
Chalom, Elizabeth
Hsu, Joyces
Zisman, Devy
Mellins, Elizabeth D.
JOURNAL OF RHEUMATOLOGY, 2021, 48 (04) : 567 - 574
[47] Inflammatory Bowel Disease in Children with Systemic Juvenile Idiopathic Arthritis
Fox, Emily
Hsu, Joyce
Chalom, Elizabeth
Sertial, Sarah
Park, K. T.
Simard, Julia F.
Quartier, Pierre
Terreri, Maria Teresa
Baszis, Kevin
Borocco, Charlotte
Prahalad, Sampath
Reinhardt, Adam
Schonenberg, Dieneke
Mellins, Elizabeth D.
Zisman, Devy
ARTHRITIS & RHEUMATOLOGY, 2015, 67
[48] Gene Expression Changes in Polyarticular Juvenile Idiopathic Arthritis Following Tofacitinib Treatment
Eloseily, Esraa
Pickering, Alex
Dhakal, Sanjeev
Grom, Alexei
Brunner, Hermine
Thornton, Sherry
ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 33 - 35
[49] CANAKINUMAB IN SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS: IMPACT ON THE RATE AND CLINICAL PRESENTATION OF MACROPHAGE ACTIVATION SYNDROME
Grom, A. A.
Brunner, H. I.
Ruperto, N.
Martini, A.
Lovell, D.
Pascual, V.
Lheritier, K.
Abrams, K.
Ilowite, N.
ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 578 - 578
[50] Canakinumab First or Second Choice in Systemic Juvenile Idiopathic Arthritis Experience from Clinical Practice
Horneff, Gerd
Foeldvari, Ivan
Tenbrock, Klaus
Minden, K.
Kuemmerle-Deschner, Jasmin B.
ARTHRITIS & RHEUMATOLOGY, 2017, 69

← 1 2 3 4 5 →